Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Dose-Dependent Effects of Oral THC in Healthy Cannabis-Experienced Adults
NCT07346690Phase 1Not yet recruiting
- Sponsor
- University of Calgary
- Start
- Feb 2026
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of AVCN319301b (4 arms), sponsored by University of Calgary. Primary endpoint: State Trait Anxiety Inventory - State. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
AVCN319301b
Beyond the preview
Go deeper on NCT07346690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07346690.